|
A Major Nutritional Effect on Intestinal Stem Cells and Tumors
|
1R01CA214625-01A1
|
$294,022
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
(7) Novel imaging devices for measurement and control of tumor microenvironments
|
5R01CA216248-02
|
$607,904
|
$607,904
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
|
5R01CA168912-05
|
$320,588
|
|
HE, YUKAI
|
AUGUSTA UNIVERSITY
|
|
Chemotherapy-induced MDSCs and antitumor immunity
|
5R01CA215523-02
|
$347,700
|
|
ZHOU, GANG
|
AUGUSTA UNIVERSITY
|
|
Discovery, Biology and Risk of Inherited Variants in Glioma
|
1R01CA217105-01A1
|
$1,043,807
|
|
BONDY, MELISSA
|
BAYLOR COLLEGE OF MEDICINE
|
|
MECHANISMS OF AR-ER COLLABORATION IN HORMONE RESISTANCE AND METASTASIS OF BREAST CANCER
|
5R01CA207270-02
|
$362,569
|
$362,569
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of KLF4 suppression in pediatric leukemia
|
5R01CA207086-02
|
$370,641
|
|
LACORAZZA, DANIEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Drugging the Undruggable Coactivators using Small Molecule Inhibitors
|
5R01CA207701-02
|
$426,451
|
$426,451
|
WANG, JIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
5R01CA155769-07
|
$410,877
|
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
The role and mechanism of FTO in leukemogenesis and drug response
|
5R01CA214965-03
|
$444,571
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
|
5R01CA213131-02
|
$430,377
|
|
KORTYLEWSKI, MARCIN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting the ARHGAP25 pathway in acute myelogenous leukemia stem cells
|
5K08CA201591-02
|
$169,560
|
|
WANG, LEO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Control of tumor growth and metastasis by the cytokine TSLP
|
5R01CA182783-05
|
$362,503
|
$362,503
|
ZIEGLER, STEVEN
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Humanized Anti-Renalase Antibodies for Unresectable Melanoma
|
1R43CA224463-01
|
$299,996
|
|
BERKOWITZ, BARRY
|
BESSOR PHARMA, LLC
|
|
Functional analysis of a tissue context-dependent role for beta-TRCP in lipid metabolism and tumorigenesis
|
9R01CA229307-05A1
|
$374,063
|
|
WEI, WENYI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Single-molecule mechanical detection of protein and microRNA cancer biomarkers
|
5R21CA212827-02
|
$248,117
|
|
WONG, WESLEY
|
BOSTON CHILDREN'S HOSPITAL
|
|
The Role of DLST in Leukemogenesis
|
1R01CA215059-01A1
|
$377,437
|
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Functional characterization of the telomere repeat containing RNA, TERRA, in telomere maintenance
|
5R01CA214880-02
|
$237,158
|
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Investigating the cytomegalovirus link to glioblastoma using a novel mouse model
|
5R01CA195532-04
|
$377,464
|
|
CHIOCCA, E
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Mucins and immune cell interactions in ovarian cancer pathogenesis & progression
|
5R35CA197605-03
|
$966,086
|
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Selenoproteins as targets for cancer prevention
|
5R01CA080946-18
|
$223,000
|
|
GLADYSHEV, VADIM
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
The Metabolic Pathogenesis of Chromophobe Renal Cell Carcinoma
|
1R01CA216922-01A1
|
$426,489
|
|
HENSKE, ELIZABETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Clinical Evaluation of an Implantable Lab-in-a-patient microdevice that measures in-situ response to therapies in advanced ovarian cancer
|
1R21CA216796-01A1
|
$183,736
|
|
JONAS, OLIVER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-19
|
$228,408
|
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
BORG: Role for a Novel lncRNA in Mediating Breast Cancer Metastasis and Dormancy
|
5F30CA203233-03
|
$49,524
|
$49,524
|
GOODING, ALEX
|
CASE WESTERN RESERVE UNIVERSITY
|
|
EPHA6 as a novel candidate driver gene in colon cancer
|
5R01CA204549-03
|
$362,569
|
|
GUDA, KISHORE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
MR Fingerprinting and Computerized Decision Support for Prostate Cancer
|
5R01CA208236-02
|
$636,773
|
|
GULANI, VIKAS
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeting BET proteins in Triple Negative Breast Cancer
|
5R01CA206505-03
|
$366,913
|
$366,913
|
KERI, RUTH
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Targeted MRI contrast agents for differential diagnosis of prostate cancer
|
5R01CA211762-02
|
$424,315
|
|
LU, ZHENG-RONG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
5U10CA180853-05
|
$1,187,291
|
$267,140
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Biomarkers for Reducing Mortality of Cancers of the Colon and Esophagus
|
5U01CA152756-08
|
$706,863
|
|
MARKOWITZ, SANFORD
|
CASE WESTERN RESERVE UNIVERSITY
|
|
SLX4IP and a novel regulatory network in breast cancer metastasis and dormancy
|
5F30CA213892-02
|
$44,524
|
$44,524
|
ROBINSON, NATHANIEL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Mechanism and Impact of an Interaction Between Keratin 19 and a Regulator of Gene Expression
|
1R15CA213071-01A1
|
$473,050
|
$473,050
|
CHUNG, BYUNG MIN
|
CATHOLIC UNIVERSITY OF AMERICA
|
|
Prostate Cancer Bone Metastasis Biology and Targeting
|
5P01CA098912-14
|
$1,636,904
|
|
CHUNG, LELAND
|
CEDARS-SINAI MEDICAL CENTER
|
|
Omics Approach to Interrogating Mechanism of ETV5 in Glioma
|
5F31CA213926-02
|
$38,124
|
|
PARK, HANNAH
|
CEDARS-SINAI MEDICAL CENTER
|
|
Increased chemoprevention by a mixture of three phytochemicals in prostate cancer
|
5R03CA208221-02
|
$77,704
|
|
WANG, PIWEN
|
CHARLES R. DREW UNIVERSITY OF MED & SCI
|
|
COG NCTN Solid Malignancy Integrated Translational Science Center
|
5U10CA180884-05
|
$192,024
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Role of LMO1 in Neuroblastoma Initiation and Maintenance
|
5R01CA180692-04
|
$606,838
|
|
MARIS, JOHN
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
The Myc - miR-17-92 axis in colorectal cancers
|
5R01CA196299-04
|
$384,300
|
|
THOMAS-TIKHONENKO, ANDREI
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Clinical significance and mechanism of action of exosomal microRNAs in Neuroblastoma chemoresistance.
|
1R01CA219024-01A1
|
$123,772
|
|
FABBRI, MULLER
|
CHILDREN'S HOSPITAL OF LOS ANGELES
|
|
Mechanism of non-oncogene addiction
|
1R01CA211594-01A1
|
$363,713
|
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Hemostatic Factors Drive Prostate Cancer Pathogenesis
|
5R01CA193678-03
|
$356,850
|
|
PALUMBO, JOSEPH
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Coagulation factors as modifiers of the colon cancer microenvironment
|
5R01CA204058-03
|
$356,850
|
|
PALUMBO, JOSEPH
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
Proteomics of Metastatic and Non-Metastatic Uveal Melanoma
|
5R21CA209500-02
|
$172,369
|
|
CRABB, JOHN
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Development of an LMIC-adapted Thermocoagulation Prototype for the Treatment of Cervical Pre-cancer.
|
1R01CA218195-01A1
|
$669,209
|
|
CREMER, MIRIAM
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
MYC as a Biomarker in Aggressive Non-Hodgkin Lymphoma
|
5R01CA187415-04
|
$457,439
|
|
LI, YONG
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Small molecule Inhibitors of steroid receptor coactivator to treat breast cancer
|
1R41CA217561-01A1
|
$223,781
|
$223,781
|
LONARD, DAVID
|
COACTIGON, INC.
|
|
CSHL-JAX Patient-Derived Models of Pancreatic Cancer as Systems for Investigating Tumor Heterogeneity
|
1U01CA224013-01
|
$881,016
|
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
Engineering of bacterial probiotics for the detection and treatment of hepatocellular carcinoma
|
1F32CA225145-01
|
$59,038
|
|
SINGER, ZAKARY
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
Total relevant funding to Breast for this search: $71,212,877
|